Abstract
Peptide drugs have received more attention as potential next-generation drugs or drug leads. Such attention is primarily due to the higher target selectivities and efficiencies of peptide drugs. Moreover, peptide drugs typically have lower accumulation rates and toxicities. Although peptide drugs have advanced significantly in the 21st century, two bottlenecks (disadvantages) primarily hinder peptide drug research and development compared to small molecule drugs. One bottleneck is the identification of a valuable peptide in a complicated pool of crude products; the other bottleneck is the ability to prepare sufficient amounts of peptides for preclinical or clinical trials. This review discusses important methodologies for addressing these two bottlenecks.
Keywords: Extracellular expression, intracellular expression, in vitro screening, in vivo screening, methodology, peptide.
Current Proteomics
Title:The Development of High-throughput Identification and Heterologous Expression of Valuable Peptides/Proteins
Volume: 14 Issue: 1
Author(s): Chang-Jun Liu, Lei Wu, Er Meng and Dong-Yi Zhang
Affiliation:
Keywords: Extracellular expression, intracellular expression, in vitro screening, in vivo screening, methodology, peptide.
Abstract: Peptide drugs have received more attention as potential next-generation drugs or drug leads. Such attention is primarily due to the higher target selectivities and efficiencies of peptide drugs. Moreover, peptide drugs typically have lower accumulation rates and toxicities. Although peptide drugs have advanced significantly in the 21st century, two bottlenecks (disadvantages) primarily hinder peptide drug research and development compared to small molecule drugs. One bottleneck is the identification of a valuable peptide in a complicated pool of crude products; the other bottleneck is the ability to prepare sufficient amounts of peptides for preclinical or clinical trials. This review discusses important methodologies for addressing these two bottlenecks.
Export Options
About this article
Cite this article as:
Liu Chang-Jun, Wu Lei, Meng Er and Zhang Dong-Yi, The Development of High-throughput Identification and Heterologous Expression of Valuable Peptides/Proteins, Current Proteomics 2017; 14 (1) . https://dx.doi.org/10.2174/1570164614666161207162711
DOI https://dx.doi.org/10.2174/1570164614666161207162711 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Transgenic Mouse Models of Alzheimer Disease: Developing a Better Model as a Tool for Therapeutic Interventions
Current Pharmaceutical Design Rationale of Hyperbaric Oxygenation in Cerebral Vascular Insult
Current Vascular Pharmacology Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity
Current Immunology Reviews (Discontinued) Human Evolution, Life History Theory, and the End of Biological Reproduction
Current Aging Science Are B Cells a Potential Target for Therapeutic Intervention in the Classical T Cell-Mediated Autoimmune Disease Type 1 Diabetes?
Inflammation & Allergy - Drug Targets (Discontinued) Strain Typing of Mycoplasma pneumoniae and its Value in Epidemiology
Current Pediatric Reviews Inflammation and Innate Immune Response Against Viral Infections in Marine Fish
Current Pharmaceutical Design Hallucinations and Delusions in Children and Adolescents
Current Psychiatry Reviews Nanomaterials-based Polymerase Chain Reactions for DNA Detection
Current Organic Chemistry Benzo[a]pyrene Toxicity and Inflammatory Disease
Current Rheumatology Reviews Recent Advances in the Development of Anti-Infective Prophylactic and/or Therapeutic Agents Based on Toll-Like Receptor (TLRs)
Recent Patents on Anti-Infective Drug Discovery Understanding Respiratory Syncytial Virus Infection to Improve Treatment and Immunity
Current Molecular Medicine Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry Multimodality Imaging in Acute Ischemic Stroke
Current Medical Imaging Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem
Current Drug Targets Laboratory Techniques for Human Viral Encephalitis Diagnosis
Infectious Disorders - Drug Targets Potentiometric Sensors for Organic Analytes: Insights to Proceed to Miniaturization
Current Pharmaceutical Analysis Immunology and Epilepsy: Clinical and Experimental Evidence
Current Immunology Reviews (Discontinued) Measles Virus Induced Immunosuppression: Targets and Effector Mechanisms
Current Molecular Medicine Antiviral Activities of Human Host Defense Peptides
Current Medicinal Chemistry